Atlas Trials

Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

Clinical trial NCT04611139 · WITHDRAWN

Trial details

NCT number
NCT04611139
Sponsor
HonorHealth Research Institute
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
SCCOHTOvarian Clear Cell TumorOvarian Endometrioid AdenocarcinomaEndometrial Cancer
Start date
2021-12-31
Primary completion
2023-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.